SuperworthCG Oncology shares outstanding CGON
Diluted shares outstanding, averaged over each quarter, from 2023.
- Latest quarter, to Jun 30, 2026
- 88.2M
- On a year earlier
- +15.7%
- more shares
CG Oncology had 88.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 15.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 80M | +16% |
| FY2024 | 69M | +1239% |
| FY2023 | 5.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 88.2M | +16% | |
| Q1 FY26 | 84.5M | +11% | |
| Q4 FY25 | 80M | +16% | |
| Q3 FY25 | 76.7M | +14% | |
| Q2 FY25 | 76.2M | +14% | |
| Q1 FY25 | 76.2M | +62% | |
| Q4 FY24 | 69M | +1239% | |
| Q3 FY24 | 67.1M | +1432% | |
| Q2 FY24 | 66.6M | +1601% | |
| Q1 FY24 | 47.1M | +1121% | |
| Q4 FY23 | 5.2M | n/a | |
| Q3 FY23 | 4.4M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on CG Oncology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.